Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000794198 | SCV000933592 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV001170025 | SCV001251699 | pathogenic | not provided | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002424805 | SCV002731408 | uncertain significance | Inborn genetic diseases | 2023-12-19 | criteria provided, single submitter | clinical testing | The c.2172dupT (p.P725Sfs*46) alteration, located in exon 9 (coding exon 9) of the WNK1 gene, consists of a duplication of T at position 2172, causing a translational frameshift with a predicted alternate stop codon after 46 amino acids. Frameshift alterations are typically deleterious in nature (Richards, 2015). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |